Lack of replication of a previously reported association between polymorphism in the 3'UTR of the alpha-synuclein gene and Parkinson's disease in Chinese subjects

Neuroscience Letters

Volumn 479, Issue 1, 2010, Pages 31-33

  Hu, F Y ^a,b   Hu, W B ^a,c   Liu, L ^a   Yu, L H ^a   Xi, J ^a   He, X H ^a   Zhu, M R ^a   Liu, Z L ^d   Xu, Y M ^a  

^a SICHUAN UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c Huaguo Hospital   (China)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

Alpha synuclein; Case control study; Parkinson's disease; Rs356165; Single nucleotide polymorphism

Indexed keywords

ALPHA SYNUCLEIN; 3' UNTRANSLATED REGION; SNCA PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DNA SEQUENCE; GENETICS; MIDDLE AGED;

3' UNTRANSLATED REGIONS; ALPHA-SYNUCLEIN; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 77953704225     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2010.05.022     Document Type: Article

References (23)

1. Eriksen J.L., Dawson T.M., Dickson D.W., Petrucelli L. Caught in the act: alpha-synuclein is the culprit in Parkinson's disease. Neuron 2003, 40:453-456.
2. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann. N. Y. Acad. Sci. 2003, 991:1-14.
3. Farrer M., Maraganore D.M., Lockhart P., Singleton A., Lesnick T.G., de Andrade M., West A., de Silva R., Hardy J., Hernandez D. Alpha-synuclein gene haplotypes are associated with Parkinson's disease. Hum. Mol. Genet. 2001, 10:1847-1851.
4. Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2001, 2:492-501.
5. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
6. Izumi Y., Morino H., Oda M., Maruyama H., Udaka F., Kameyama M., Nakamura S., Kawakami H. Genetic studies in Parkinson's disease with an alpha-synuclein/NACP gene polymorphism in Japan. Neurosci. Lett. 2001, 300:125-127.
7. Khan N., Graham E., Dixon P., Morris C., Mander A., Clayton D., Vaughan J., Quinn N., Lees A., Daniel S., Wood N., de Silva R. Parkinson's disease is not associated with the combined alpha-synuclein/apolipoprotein E susceptibility genotype. Ann. Neurol. 2001, 49:665-668.
8. Krüger R., Vieira-Saecker A.M., Kuhn W., Berg D., Müller T., Kühnl N., Fuchs G.A., Storch A., Hungs M., Woitalla D., Przuntek H., Epplen J.T., Schöls L., Riess O. Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann. Neurol. 1999, 45:611-617.
9. Mizuta I., Satake W., Nakabayashi Y., Ito C., Suzuki S., Momose Y., Nagai Y., Oka A., Inoko H., Fukae J., Saito Y., Sawabe M., Murayama S., Yamamoto M., Hattori N., Murata M., Toda T. Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease. Hum. Mol. Genet. 2006, 15:1151-1158.
10. Mueller J.C., Fuchs J., Hofer A., Zimprich A., Lichtner P., Illig T., Berg D., Wüllner U., Meitinger T., Gasser T. Multiple regions of alpha-synuclein are associated with Parkinson's disease. Ann. Neurol. 2005, 57:535-541.
11. Myhre R., Toft M., Kachergus J., Hulihan M.M., Aasly J.O., Klungland H., Farrer M.J. Multiple alpha-synuclein gene polymorphisms are associated with Parkinson's disease in a Norwegian population. Acta Neurol. Scand. 2008, 118:320-327.
12. Pals P., Lincoln S., Manning J., Heckman M., Skipper L., Hulihan M., Van den Broeck M., De Pooter T., Cras P., Crook J., Van Broeckhoven C., Farrer M.J. Alpha-synuclein promoter confers susceptibility to Parkinson's disease. Ann. Neurol. 2004, 56:591-595.
13. Parsian A., Racette B., Zhang Z.H., Chakraverty S., Rundle M., Goate A., Perlmutter J.S. Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease. Neurology 1998, 51:1757-1759.
14. Polymeropoulos M.H., Lavedan C., Leroy E., Ide S.E., Dehejia A., Dutra A., Pike B., Root H., Rubenstein J., Boyer R., Stenroos E.S., Chandrasekharappa S., Athanassiadou A., Papapetropoulos T., Johnson W.G., Lazzarini A.M., Duvoisin R.C., Di Iorio G., Golbe L.I., Nussbaum R.L. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047.
15. Rocca W.A. Prevalence of Parkonson's disease in China. Lancet Neurol. 2005, 4:328-329.
16. Ross O.A., Gosal D., Stone J.T., Lincoln S.J., Heckman M.G., Irvine G.B., Johnston J.A., Gibson J.M., Farrer M.J., Lynch T. Familial genes in sporadic disease: common variants of alpha-synuclein gene associate with Parkinson's disease. Mech. Ageing. Dev. 2007, 128:378-382.
17. Shults C.W. Lewy bodies. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:1661-1668.
18. Spadafora P., Annesi G., Pasqua A.A., Serra P., Cirò Candiano I.C., Carrideo S., Tarantino P., Civitelli D., De Marco E.V., Nicoletti G., Annesi F., Quattrone A. NACP-REP1 polymorphism is not involved in Parkinson's disease: a case-control study in a population sample from southern Italy. Neurosci. Lett. 2003, 351:75-78.
19. Spillantini M.G., Schmidt M.L., Lee V.M., Trojanowski J.Q., Jakes R., Goedert M. Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840.
20. Tan E.K., Chai A., Teo Y.Y., Zhao Y., Tan C., Shen H., Chandran V.R., Teoh M.L., Yih Y., Pavanni R., Wong M.C., Puvan K., Lo Y.L., Yap E. Alpha-synuclein haplotypes simplicated in risk of Parkinson's disease. Neurology 2004, 62:128-131.
21. Tan E.K., Matsuura T., Nagamitsu S., Khajavi M., Jankovic J., Ashizawa T. Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor?. Neurology 2000, 54:1195-1198.
22. Touchman J.W., Dehejia A., Chiba-Falek O., Cabin D.E., Schwartz J.R., Orrison B.M., Polymeropoulos M.H., Nussbaum R.L. Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element. Genome Res. 2001, 11:78-86.
23. Winkler S., Hagenah J., Lincoln S., Heckman M., Haugarvoll K., Lohmann-Hedrich K., Kostic V., Farrer M., Klein C. α-Synuclein and Parkinson disease susceptibility. Neurology 2007, 69:1745-1750.